Arrowstreet Capital Portfolio holdings
AUM
$141B
This Quarter Return
+14.83%
1 Year Return
+32.28%
3 Year Return
+131.72%
5 Year Return
+249.71%
10 Year Return
+627.08%
AUM
$42.3B
AUM Growth
+$42.3B
(+11%)
Cap. Flow
-$110M
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
2,012
New
692
Increased
652
Reduced
338
Closed
308
Top Buys
| 1 |
Rio Tinto
RIO
|
$387M |
| 2 |
IBM
IBM
|
$244M |
| 3 |
ConocoPhillips
COP
|
$240M |
| 4 |
UN
Unilever NV New York Registry Shares
UN
|
$231M |
| 5 |
Boeing
BA
|
$206M |
Top Sells
| 1 |
Microsoft
MSFT
|
$663M |
| 2 |
Visa
V
|
$460M |
| 3 |
SHPG
Shire pic
SHPG
|
$417M |
| 4 |
TSMC
TSM
|
$416M |
| 5 |
Apple
AAPL
|
$323M |
Sector Composition
| 1 | Technology | 22.1% |
| 2 | Healthcare | 20.31% |
| 3 | Consumer Discretionary | 13.59% |
| 4 | Financials | 11.64% |
| 5 | Industrials | 7.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Mastercard
MA
$538B
| $931M | 2.2% | 3,955,200 -77,997 | -2% | -$18.4M |
|
|
2
Rio Tinto
RIO
$102B
| $761M | 1.8% | 12,926,674 +6,581,224 | +104% | +$387M |
|
3
Bristol-Myers Squibb
BMY
$96B
| $703M | 1.66% | 14,738,676 -26,183 | -0.2% | -$1.25M |
|
|
4
IBM
IBM
$227B
| $691M | 1.63% | 4,894,069 +1,731,877 | +55% | +$244M |
|
5
TJX Companies
TJX
$152B
| $659M | 1.56% | 12,387,698 -1,966,806 | -14% | -$105M |
|
6
Merck
MRK
$210B
| $633M | 1.5% | 7,610,657 +1,511,692 | +25% | +$126M |
|
7
iShares MSCI South Korea ETF
EWY
$5.27B
| $624M | 1.48% | 10,241,205 -1,001,559 | -9% | -$61M |
|
8
AbbVie
ABBV
$372B
| $557M | 1.32% | 6,915,789 -228,540 | -3% | -$18.4M |
|
9
Home Depot
HD
$405B
| $555M | 1.31% | 2,893,103 -1,662,005 | -36% | -$319M |
|
10
Adobe
ADBE
$151B
| $549M | 1.3% | 2,061,971 -454,522 | -18% | -$121M |
|
|
CELG
11
DELISTED
Celgene Corp
CELG
| $548M | 1.3% | 5,807,890 +168,377 | +3% | +$15.9M |
|
12
HCA Healthcare
HCA
$94.5B
| $527M | 1.25% | 4,039,369 -31,100 | -0.8% | -$4.05M |
|
13
Intel
INTC
$107B
| $508M | 1.2% | 9,459,334 +426,404 | +5% | +$22.9M |
|
14
AstraZeneca
AZN
$248B
| $504M | 1.19% | 12,459,368 +752,118 | +6% | +$30.4M |
|
|
15
Boeing
BA
$177B
| $504M | 1.19% | 1,320,291 +540,335 | +69% | +$206M |
|
|
16
Visa
V
$683B
| $470M | 1.11% | 3,007,462 -2,945,478 | -49% | -$460M |
|
17
Novartis
NVS
$245B
| $450M | 1.06% | 4,681,206 +1,414,976 | +43% | +$136M |
|
18
GSK
GSK
$79.9B
| $427M | 1.01% | 10,221,283 +1,715,323 | +20% | +$71.7M |
|
19
UnitedHealth
UNH
$281B
| $427M | 1.01% | 1,727,299 +32,625 | +2% | +$8.07M |
|
20
Biogen
BIIB
$19.4B
| $406M | 0.96% | 1,716,590 +192,501 | +13% | +$45.5M |
|
21
Union Pacific
UNP
$133B
| $382M | 0.9% | 2,282,754 -148,139 | -6% | -$24.8M |
|
22
Intuit
INTU
$186B
| $364M | 0.86% | 1,391,021 -232,768 | -14% | -$60.8M |
|
23
Automatic Data Processing
ADP
$123B
| $348M | 0.82% | 2,179,399 -562,096 | -21% | -$89.8M |
|
24
Novo Nordisk
NVO
$251B
| $330M | 0.78% | 6,308,565 -272,798 | -4% | -$14.3M |
|
25
Canadian National Railway
CNI
$60.4B
| $327M | 0.77% | 3,656,277 +74,635 | +2% | +$6.68M |
|